scispace - formally typeset
O

Olivier Bruyère

Researcher at University of Liège

Publications -  644
Citations -  34196

Olivier Bruyère is an academic researcher from University of Liège. The author has contributed to research in topics: Osteoporosis & Medicine. The author has an hindex of 72, co-authored 579 publications receiving 24788 citations. Previous affiliations of Olivier Bruyère include HEC Paris & World Health Organization.

Papers
More filters
Journal ArticleDOI

Mortality in malnourished older adults diagnosed by ESPEN and GLIM criteria in the SarcoPhAge study.

TL;DR: This work aimed to assess malnutrition according to the ESPEN and GLIM criteria at baseline and to determine the corresponding risk of mortality during a 4‐year follow-up in community‐dwelling older adults from the SarcoPhAge study.
Journal ArticleDOI

Relevance of vitamin D in the pathogenesis and therapy of frailty

TL;DR: Several studies suggest a potential effect of vitamin D on physical frailty but large clinical trials are lacking at this time to provide solid evidence of clinical benefit.
Journal ArticleDOI

Safety of Cyclooxygenase-2 Inhibitors in Osteoarthritis: Outcomes of a Systematic Review and Meta-Analysis.

TL;DR: In a systematic review and meta-analysis of randomized, placebo-controlled trials, COX-2 inhibitors were associated with an increased risk of upper gastrointestinal AEs, especially abdominal pain, and an increasedrisk of cardiovascular AEs with COX -2 inhibitors, namely hypertension, heart failure and edema.
Journal ArticleDOI

The role of biochemical of bone turnover markers in osteoporosis and metabolic bone disease: a consensus paper of the Belgian Bone Club.

TL;DR: The Belgian Bone Club aimed to provide a state of the art on the use of biochemical markers of bone turnover in different clinical or physiological situations like in postmenopausal women, osteoporosis in men, in elderly patients, in patients suffering from bone metastasis, in Patients with chronic renal failure, in pregnant or lactating women, in intensive care patients, and in diabetics.